*.*.44.201
药智数据企业版
量身打造,体验升级
立即前往
VIP免费试用申请
登录 注册
反馈纠错 帮助中心 打印
备案号 Y国备2024000622
药品通用名称 他达拉非
英文名称/拉丁名称 Tadalafil
药品批准文号/注册证书/原料药登记号 暂无权限
生产企业 暂无权限
生产企业(英文) Apitoria Pharma Private Limited
生产企业地址 UNIT-II, SURVEY NO. 10 and 13, IDA, KAZIPALLY, GADDAPOTHARAM VILLAGE, JINNARAM MANDAL, SANGAREDDY DISTRICT, TELANGANA STATE, INDIA.
上市许可持有人 Apitoria Pharma Private Limited
上市许可持有人(英文) Apitoria Pharma Private Limited
上市许可持有人地址 UNIT-II, SURVEY NO. 10 and 13, IDA, KAZIPALLY, GADDAPOTHARAM VILLAGE, JINNARAM MANDAL, SANGAREDDY DISTRICT, TELANGANA STATE, INDIA.
境外生产药品注册代理机构 安若维他药业泰州有限公司
境外生产药品注册代理机构地址 泰州市医药高新区祥泰路196号
备案内容 暂无权限
备案机关 国家药品监督管理局药品审评中心
备案日期 2024-03-30
备注 经审查,此次备案涉及原料药登记人实际变更,请登记人按照补充申请进行申报。
数据更新时间:2025-09-25

他达拉非备案及生产企业信息

扩展信息
Apitoria Pharma Private Limited生产的他达拉非(批号:Y20200001225); 已于2024-03-30进行备案
他达拉非
其他厂家
Y20180001768
批准日期:2025-09-08
Y20190021551
批准日期:2025-09-02
Y20220001272
批准日期:2025-08-26
Y20190000425
批准日期:2025-08-06
Y20180000994
批准日期:2025-07-07
Apitoria Pharma Private Limited
其他产品
Y20170001012
批准日期:2025-01-03
制药厂商对可能存在的多种具有警示结构的潜在致突变杂质进行补充研究。
Y20200000074
批准日期:2024-06-04
1.本品原料药申请人和生产企业的名称和地址表述发生变更,由“Aurobindo Pharma Limited,(Unit-XI), Sy. No’s. 52, 53, 58, 59, 61 to 78, 127 & 128, Pydibhimavaram Village, Sy. No’s. 1, 2, 4 to 9, 11, 29, 30, 31 & 32, Chittivalasa Village, Ranasthalam Mandal, Srikakulam District, Andhra Pradesh, India -532 409”变更为“Apitoria Pharma Private Limited,Unit-IV, Sy. No’s. 52, 53, 58, 59, 61 to 78, 127 & 128, Pydibhimavaram Village & Sy. No’s. 1, 2, 4 to 9, 11, 29, 30, 31 & 32, Chittivalasa Village, Ranasthalam Mandal, Srikakulam District, Andhra Pradesh, India, PIN: 532 409”。 2.对盐酸吡格列酮《化学原料药上市申请批准通知书》附件(生产工艺信息表)中明显笔误内容进行勘误。
Y20190021392
批准日期:2024-04-11
本品原料药申请人和生产企业的名称和地址发生变更,实际的生产地址不变。原料药申请人的名称及地址由“Aurobindo Pharma Limited, Plot No.2, Maitrivihar, Ameerpet, Hyderabad Telangana, INDIA”变更为“Apitoria Pharma Private Limited, Galaxy, Floors: 22-24, Plot No.1, Survey No. 83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad - 500 032, Telangana, India”;生产企业的名称及地址由“Aurobindo Pharma Limited, Unit-XI, Sy. No’s. 52, 53, 58, 59, 61 to 78, 127 & 128, Pydibhimavaram Village, Sy. No’s. 1, 2, 4 to 9, 11, 29, 30, 31 & 32, Chittivalasa Village, Ranasthalam Mandal, Srikakulam District, Andhra Pradesh, India -532 409”变更为“Apitoria Pharma Private Limited, Unit-IV, Sy. No’s. 52, 53, 58, 59, 61 to 78, 127 & 128, Pydibhimavaram Village & Sy. No’s. 1, 2, 4 to 9, 11, 29, 30, 31 & 32, Chittivalasa Village, Ranasthalam Mandal, Srikakulam District, Andhra Pradesh, India, PIN: 532 409”。
Y20200001156
批准日期:2024-04-02
本品原料药申请人和生产企业的名称和地址表述发生变更,由“Aurobindo Pharma Limited, Unit-I, Sy. No. 379, 385, 386, 388 to 396, Borpatla (Village), Hatnoora (Mandal), Sanga Reddy (District), Telangana, INDIA”变更为“Apitoria Pharma Private Limited, Unit I, Sy. Nos. 379, 385, 386, 388 to 396, Borpatla Village, Hathnoora Mandal, Sanga Reddy District, Telangana, India, Pin code 502296”。
Y20200001254
批准日期:2024-04-02
本品原料药申请人和生产企业的名称和地址表述发生变更,由“Aurobindo Pharma Limited, Unit-XI, Sy. No. 1/22, 2/1 to 5, 6 to 18, 61 to 69, Pydibhimavaram (Village), Ranasthalam (Mandal), Srikakulam (District), Andhra Pradesh (State), INDIA”变更为“Apitoria Pharma Private Limited, Unit-IV, Sy. No’s. 52, 53, 58, 59, 61 to 78, 127 & 128, Pydibhimavaram Village & Sy. No’s. 1, 2, 4 to 9, 11, 29, 30, 31 & 32, Chittivalasa Village, Ranasthalam Mandal, Srikakulam District, Andhra Pradesh, India, PIN: 532 409”。
发布